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Background: Chikungunya virus (CHIKV) is an arthritogenic member of the Alphavirus genus (family Togaviridae)
transmitted by Aedes mosquitoes. CHIKV is now known to target non hematopoietic cells such as epithelial,
endothelial cells, fibroblasts and to less extent monocytes/macrophages. The type I interferon (IFN) response is an
early innate immune mechanism that protects cells against viral infection. Cells express different pattern recognition
receptors (including TLR7 and RIG-I) to sense viruses and to induce production of type I IFNs which in turn will bind
to their receptor. This should result in the phosphorylation and translocation of STAT molecules into the nucleus to
promote the transcription of IFN-stimulated antiviral genes (ISGs). We herein tested the capacity of CHIKV clinical
isolate to infect two different human fibroblast cell lines HS 633T and HT-1080 and we analyzed the resulting type I
IFN innate immune response.
Methods: Indirect immunofluorescence and quantitative RT-PCR were used to test for the susceptibility of both
fibroblast cell lines to CHIKV.
Results: Interestingly, the two fibroblast cell lines HS 633T and HT-1080 were differently susceptible to CHIKV
infection and the former producing at least 30-fold higher viral load at 48 h post-infection (PI). We found that the
expression of antiviral genes (RIG-I, IFN-β, ISG54 and ISG56) was more robust in the more susceptible cell line HS
633T at 48 h PI. Moreover, CHIKV was shown to similarly interfere with the nuclear translocation of pSTAT1 in both
cell lines.
Conclusion: Critically, CHIKV can control the IFN response by preventing the nuclear translocation of pSTAT1 in
both fibroblast cell lines. Counter-intuitively, the relative resistance of HT-1080 cells to CHIKV infection could not be
attributed to more robust innate IFN- and ISG-dependent antiviral responses. These cell lines may prove to be
valuable models to screen for novel mechanisms mobilized differentially by fibroblasts to control CHIKV infection,
replication and spreading from cell to cell.
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Chikungunya virus (CHIKV) is an arthritogenic member
of the Alphavirus genus (family Togaviridae) transmitted
by Aedes mosquitoes [1]. CHIKV is responsible for a
febrile illness called CHIK fever which has an incubation
period usually comprised between 3 to 7 days (range,
2-12 days) [2,3]. The first cases of patients infected by
CHIKV described acute onset of high fever (temperature
usually above 38.9°C), severe joint pain, and rash as classic
clinical symptoms [4]. CHIKV has been responsible for
explosive outbreaks since 2005 in the Indian Ocean.
CHIKV targets human non hematopoietic cells including
fibroblasts, epithelial, neuronal and endothelial cells and to
less extent hematopoietic cells (e.g. monocyte-derived
macrophages and primary cultures of macrophages)
[5–10]. CHIKV is an enveloped virus and its genome con-
sists in a positive single-stranded RNA molecule of 11805
nucleotides long [11]. It is composed of two open reading
frames (ORFs). The 5’ ORF encodes non-structural pro-
teins (nsP1 to nsP4) which are multifunctional and form
together the virus replicase. The 3’ ORF encodes the struc-
tural proteins (capsid [C], envelope glycoproteins [E1 and
E2], E3 and 6 k) [12,13,14].
Induction of type I interferons (IFN-α and β) by intra-
cellular sensors such as the Toll-like receptors (TLRs)
located in endosomes (e.g. TLR7) and the cytosolic RIG-
like receptors (RLRs) (e.g. RIG-I) represents an early in-
nate immune response against viruses [15-18] TLR7
recognizes single-strand RNA [19-21] whereas RIG-I
detects viral genomic RNA bearing 5’-triphosphates, sin-
gle and double-strand RNAs (dsRNA) [22]. Interaction
of RIG-I DExD/H box domain with viral dsRNA induces
conformational changes which promotes downstream
signaling cascade. The mitochondrial antiviral-signaling
protein (MAVS, also known as VISA, Cardiff or IPS-1),
an adaptator molecule, is then recruited and activates
the tank binding kinase 1 (TBK1 also IKKE in lymphoid
cells). TBK1 thus phosphorylates the interferon regula-
tory factor 3 (IRF-3) at specific serine residues [23,24].
Then IRF-3 dimerizes and translocates into the nucleus
to promote the expression of IFN-α and β [25]. IFN
response is initiated by the binding of type I IFNs to the
cell surface IFN-α/β receptor (IFNAR) in an autocrine
and paracrine manner [26,27]. IFNAR subsequently acti-
vates the Janus kinases proteins (Jak1 and Tyk2), which
in turn phosphorylate signal transducers and activators
of transcription 1 and 2 (STAT1 and STAT2) [28]. Phos-
phorylated STAT1 and STAT2 form heterodimers, mi-
grate into the nucleus and associate with IRF-9 (also
known as p48 or ISGF-3γ) to form a transcription factor
complex termed IFN-stimulated gene factor 3 (ISGF-3)
[26]. Active ISGF-3 interacts with a specific DNA
sequence called the IFN-stimulated response element
(ISRE) present in the promoter region of IFN-stimulatedgenes (ISGs) to promote ISG transcription. The expres-
sion of various ISGs is induced to clear viral infection,
including the protein kinase R (PKR) which activates the
shutdown of protein translation [29,30]. Recent investi-
gation of innate immune reaction in human fibroblasts
showed that CHIKV induces innate immune activation
via the adaptor molecule IPS-1 in human fibroblasts
[31]. In this work, we deciphered further the down-
stream innate immune response of two human fibroblast
cell lines HS 633T and HT-1080 infected by CHIKV on
the ground that they showed differential capacity to be
infected and to replicate CHIKV.
Results
The human fibroblast cell lines HS 633T and HT-1080 are
differently susceptible to CHIKV infection
To evaluate their susceptibility to the virus, HS 633T and
HT-1080 cells were grown on glass coverslips in 24 well
plates and incubated for 48 h with a MOI of 1 of the clin-
ical CHIKV isolate clone #4 [32]. In mock-infected cells
(CTL), no CHIKV was detected by immunostaining
(Figure 1Aa, c and g, i). At 48 h post infection (PI), 63.02%
± 14.48 of HS 633T cells were stained for CHIKV
(Figure 1B). The infection spreads in larger clusters from
the initially infected cells (Figure 1Ad, f). Surprisingly at
the same time point, only 3.62% ± 1.83 of HT-1080 cells
were infected by CHIKV (Figure 1B). The infection did
not spread in clusters in HT-1080 cells since infected cells
were found isolated at 48 h PI (Figure 1Aj, l). These results
indicate that HS 633T are highly susceptible to CHIKV in-
fection while HT-1080 cells are less susceptible. Next, we
wanted to evaluate the ability of both fibroblast cell lines
to produce viral progeny in the medium. Interestingly at
8 h post-infection, identical levels of CHIKV RNA copies
were detected in the supernatant of both cell lines
(1.68x107 ± 1.23x106 viral RNA copies/mL in HS 633T
compared to 1.46x107 ± 3.70x105 in HT-1080) whereas at
24 and 48 h PI the number of viral RNA copies was clearly
higher in HS 633T compared to HT-1080 cells
(Figure 1C). For instance, 3.70x108 ± 6.74x107 viral RNA
copies/mL were detected in HS633T versus 4.26x107
± 2.80x106 in HT-1080 at 24 h PI. At 48 h PI the values
reached 7.03x109 ± 5.31x108 in HS 633T and 2.22x108
± 2.45x107 in HT-1080).
Robust HS 633T- and milder HT-1080- innate immune
responses against CHIKV
We next investigated whether the expression of antiviral
genes from the IFN pathway was differentially modu-
lated by CHIKV in both fibroblast cell lines. We used
GAPDH as a housekeeping gene and to compare the
relative expression between both cell lines. First, we
found that both cell lines expressed equally well the
receptors involved in RNA virus sensing (RIG-I and







































































Figure 1 Human fibroblast cell lines HS 633T and HT-1080 are differently susceptible to chikungunya virus (CHIKV) infection. (A)
Immunostaining (polyclonal anti-CHIKV, green) of HS 633T and HT-1080 cells infected with CHIKV MOI of 1 (d, e, f and j, k, l respectively) or mock-
infected (a, b, c and g, h, i respectively). Nuclei were stained with DAPI (blue), view X200. The experiments were performed in triplicate. (B)
Percentage of HS 633T and HT-1080 CHIKV-infected (green staining) at a MOI of 1 at 48 h post-infection. Green fluorescent cells were counted in
three observation fields and results are expressed as mean ± standard error. (C) Quantification of the viral load by real time qRT-PCR from HS
633T and HT-1080 supernatants infected with CHIKV MOI 1 for 8, 24 and 48 h. The experiment was done in duplicate and results are expressed as
mean ± standard error.
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and ISG56) in basal conditions (Figure 2A, B).
In response to CHIKV infection, the relative expression of
RIG-I significantly increased in HS 633T at 8 h (1.51x10-1 ±
1.66x10-2, p < 0.05), 24 h (1.28x10-1 ± 2.29x10-2, p < 0.05)
and 48 h PI (2.68x10-1 ± 3.12x10-2, p < 0.001) when com-
pared to mock-infected cells (2.46x10-2 ± 2.02x10-3)
(Figure 2A). The same modifications in RIG-I expression
was noted in infected HT-1080 (Figure 2B). Interestingly, wefound higher expression of RIG-I in infected HS 633T when
compared to infected HT-1080 at 24 h (p < 0.05) and 48 h
PI (p < 0.001). The relative expression of IPS-1 (data not
shown) and TLR7 (Figure 2A, B) were not significantly
affected in both cell lines following CHIKV infection.
The relative expression of IFN-β was increased signifi-
cantly at 48 h PI in HS 633T (3.96x10-4 ± 1.67x10-4,
p < 0.05) (Figure 2A) but was not affected in HT-1080
(Figure 2B). Moreover, the relative expression of IFN-β
RIG-I




























































































































































Figure 2 CHIKV modulates the expression of the IFN pathway and IFN-stimulated genes in both human fibroblast cell lines HS 633T
and HT-1080. Relative expression of RIG-I, TLR7, IFN-β, ISG20, ISG54 and ISG56 from cells infected with CHIKV MOI of 1 for 8, 24, 48 h and
mock-infected cell (CTL) in HS 633T (A) or HT-1080 (B) as assessed by real-time quantitative PCR. All experiments were done in triplicates and
results are expressed as mean ± standard error (*: p < 0.05; **: p < 0.01; ***: p < 0.001).
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HT-1080 at 48 h PI (1.89x10-5 ± 8.43x10-6 for HT-1080,
p < 0.01).
All three ISGs tested were significantly upregulated in
HS 633T-infected cells at 48 h PI while more modest
upregulation were observed in HT-1080-infected cells for
ISG54 (8 h) and ISG56 (48 h) PI and not for ISG20. For
instance, the relative expression of ISG54 was significantly
higher in HS 633T than in HT-1080 at 24 h (1.03x10-2 ±
1.84x10-3 versus 4.14x10-3 ± 9.90x10-4, p < 0.05) and 48 h
PI (1.99x10-2 ± 2.67x10-3 versus 4.55x10-3 ± 4.24x10-4,
p < 0.001). Similarly, the relative expression of ISG56 was
significantly higher in HS 633T than in HT-1080 at 24 h
(8.04x10-2 ± 1.65x10-2 versus 2.31x10-2 ± 4.77x10-3,
p < 0.001) and at 48 h PI (1.38x10-1 ± 1.05x10-2 versus
8.24x10-2 ± 6.90x10-3, p < 0.001).
These results suggest that the relative resistance of
HT-1080 to be infected and replicate CHIKV cannot be
attributed to higher expression of antiviral genes such as
IFN-β and ISGs involved in the innate immune
response.
CHIKV interferes with the nuclear translocation of pSTAT1
in both HS 633T and HT-1080 cell lines
We next examined the capacity of CHIKV to control
the nuclear translocation of phosphorylated STAT1
(pSTAT1) in both human fibroblast cell lines. As
expected, pSTAT1 colocalized with DAPI staining indi-
cating that pSTAT1 translocated into the nucleus of the
large majority of HS 633T cells in response to exogenous
IFN-α (Figure 3A: d, e). In CHIKV-infected HS 633T
cells, CHIKV E1 was detected (Figure 3Ai) whereas
pSTAT1 staining (nuclear and cytoplasmic stainings)
could not be observed (Figure 3Ah). In CHIKV-infected
and subsequently stimulated with IFN-α, less than 25%
of cells were pSTAT1+ (Figure 3Ak, p < 0.01) when
compared to 100% following IFN-α stimulation alone.
Interestingly, we found that pSTAT1+ nuclei (long
arrow) were present in CHIKV negative cells next to
infected cells (Figure 3A; large arrow).
To test if CHIKV was capable of interfering with the
nuclear translocation of pSTAT1 in both HS 633T and
HT-1080, the number of cells stained for nuclear
pSTAT1 was counted in either mock-infected (CTL);
mock-infected and IFN-α stimulated (IFN-α); CHIKV-
infected (CHIKV); and finally CHIKV-infected (MOI of
1, 24 h) and subsequently IFN-α stimulated (30 min). In
IFN-α stimulated cells, robust levels of nuclear pSTAT1
were detected in both cell lines (HS 633T: 74.84% ± 5.18
and HT-1080: 72.98% ± 4.34). In CHIKV-infected and
IFN-α stimulated cells, levels of nuclear pSTAT1 signifi-
cantly decreased in both cell lines (HS 633T: 27.98%
± 6.33 and HT-1080: 23.61% ± 6.05, p < 0.01). Surpris-
ingly, these results suggest that the difference ofsusceptibility to CHIKV infection between HS 633T and
HT-1080 cells could not be attributed to a differential
inhibition of nuclear pSTAT1 to mediate the antiviral
response.
Discussion
CHIKV is well known to infect both non hematopoietic
and hematopoietic cells [5-10]. CHIKV not only infects
macrophages but also human fibroblasts from cognitive
tissues of different origins (skin, synovium) [5,10].
Couderc et al. demonstrated that in neonate mice with a
mild infection, CHIKV primarily targets muscles, joints
and skin fibroblasts, a cellular and tissue tropism similar
to that reported in humans [5]. In a seminal study, Sour-
isseau and colleagues have shown that skin- and lung-
derived fibroblasts (Hs 789.Sk and MRC5 respectively)
were differentially infected by CHIKV [10] but through
mechanisms ill-characterized.
In this paper we demonstrated that HS 633T cells be-
have as a susceptible fibroblast cell line to CHIKV infec-
tion in contrast to the other human fibroblast cell line
HT-1080 where only a smaller percentage of cells were
infected and released CHIKV progenies at lower levels.
We hypothesized that this difference could be due to dif-
ferential expression of TLR7 and/or RIG-I which are key
sensors to control CHIKV infection at least in mouse
embryonic fibroblasts [9]. Against our expectations, our
results didn’t support this hypothesis and arguing for the
role of additional antiviral mechanisms mobilized differ-
entially by fibroblast cell lines.
The IFN system is a powerful antiviral mechanism cap-
able of controlling most, if not all, virus infections in the
absence of a functional adaptative immunity [28]. How-
ever, our analysis did not reveal a higher expression of
IFN-β in HT-1080 and, in contrast, the expression was
significantly more robust in HS 633T cells at 48 h PI prob-
ably as a consequence of higher levels of viral RNA within
the cells. This result is consistent with a recent study on
primary human foreskin fibroblasts (HFs) [31]. White and
colleagues demonstrated that infection of HFs by CHIKV
triggered the transcription of IFN-β at 24 h PI.
Viruses have also developed several strategies to con-
trol the downstream IFN response to replicate, persist
and cause chronic diseases. Here, we showed that
CHIKV clinical isolate interfered equally well with the
nuclear translocation of activated STAT1 in HS 633T
and HT-1080 fibroblast cell models even in the presence
of exogenous recombinant IFN-α. This observation is
consistent with recent data studying CHIKV infection in
Vero cells using virus recombinant replicons [33]. In
their paper, Fros et al. found that CHIKV infection effi-
ciently blocked nuclear translocation of phosphorylated
STAT1 in response to either type I or II IFNs. Other











































Figure 3 CHIKV interferes equally with the nuclear translocation of phospho-STAT1 in both HS 633T and HT-1080 cells. (A) Double
immunostaining was performed for pSTAT1 (red) and CHIKV envelope E1 (green) using HS633T cells either mock-infected (a, b, c);
IFN-α-stimulated (d, e, f); CHIKV-infected (g, h, i); and finally CHIKV-infected and IFN-α-stimulated (j, k, l), view X600. Nuclei were stained in
blue with DAPI. All experiments were done in triplicate. (B) Percentage of HS 633T or HT-1080 cells with nuclear pSTAT1 from experiments
performed in A. Cells were counted in three random fields and the results are expressed as mean ± standard error (**: p < 0.01).
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[34,35].
We cannot exclude the possibility that HT-1080 cells
express only low levels of a functional receptor mediating
CHIKV entry, yet to be characterized, but it should be
stressed that the main differences in terms of susceptibility
was not observed at early time point (8 h) but was
evidenced at 24 h and 48 h. Counter-intuitively, the more
resistant HT-1080 was producing lower levels of three
main ISGs when compared to HS 633T cells at 48 h PI.We should further explore the possible contributions of
other antiviral genes such as RNAse-L or PKR to explain
differences between HS 633T and HT-1080 fibroblasts.
The analyses of the primary IFN and ISG responses to
CHIKV infection did not explain the differences of sus-
ceptibility of the two fibroblast cell lines and experiments
are now highly warranted to explore further possible add-
itional mechanisms. We and others have recently shown
that virus can hide into vesicles (blebs) to enter cells and
escape classical recognition and antiviral mechanisms [8]
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cells. It will be interesting to analyze the differential cap-
acity of HT-1080 and HS 633T not only to generate and
shed these blebs but also to engage macropinocytosis or
phagocytosis through specific receptors.
Conclusion
To sum up, the two human fibroblast cell lines HS 633T
and HT-1080 represent good in vitro models to study
CHIKV pathogenesis of the cognitive tissue given that
they are differently susceptible to infection, replication
and to engage an antiviral immune response. Gene pro-
filing of the two cell lines should help to identify the dif-
ferent mechanisms involved in the response to CHIKV
infection and subsequent infection of surrounding cells.
The capacity of CHIKV to spread from cell to cell at
later time point (>8 h) seems to be independent of the
levels of RIG-I, TLR7, type I IFNs and ISGs. It will be
essential to explore the contribution of novel cellular
pathways such as macropinocytosis or phagocytosis to
favor CHIKV infection of surrounding cells in spite of
the innate immune response.
Methods
Cells and virus
Human fibrosarcoma cell lines, HS 633T and HT-1080
were obtained respectively from European Collection of
Cell Cultures (ECACC, 89050201) and Pr Takashi Fujita
(Tokyo, Japan). Cells were grown in Dulbecco’s Modified
Eagle Medium (DMEM eagle, Sigma) supplemented with
10% fetal bovine serum (FBS) heat inactivated (Dutscher,
P04-43100) and completed with 2 mML-glutamine
(Dutscher, P04-80100), 100U/mL - 0.1 mg/mL penicillin
- streptomycin (Dutscher, P06-07100), 0.5 μg/mL fungi-
zone (Dutscher, P06-01001), 1 mM sodium pyruvate
(Dutscher, P04-43100). HS 633T cells were maintained
at 37°C in a humid atmosphere with 5% CO2 in Petri
dishes. We used a clinical isolate (CHIKV clone #4)
amplified from a patient’s serum sample (isolated in our
safety level 3 laboratory during the 2006 epidemic) by a
single passage on Vero cells [32].
Infection protocol
All infections were performed with CHIKV clone #4 at a
MOI of 1. First, to test the susceptibility of the fibroblast
cell lines HS 633T and HT-1080, cells were either grown
on glass coverslips in 24-well plates or in Petri dishes
until 60% of confluence and then incubated with CHIKV
for different periods (8, 24 and 48 h PI). Mock-infected
cells were prepared as a control. To compare the expres-
sion profile of HS 633T and HT-1080 innate immune
genes, cells were grown in Petri dishes and infected with
CHIKV for the same periods as above. Finally, to analyze
the nuclear translocation of pSTAT1 in HS 633T andHT-1080, cells were grown on glass coverslips in 24-well
plates until 40% of confluence and were either incubated
with recombinant human IFN-α alone (Peprotech, 300-
02A, France) for 30 min at a final concentration of
100 ng/mL, infected with CHIKV for 24 h and unstimu-
lated or infected with CHIKV for 24 h and then incu-
bated with human IFN-α for 30 min at a final
concentration of 100 ng/mL.
Immunofluorescence
Cells were washed twice in PBS, fixed for 5 min in cold
absolute ethanol, dried for 10 min and conserved at
−20°C. Cells were permeabilized with cold acetone for
30 sec, washed with PBS and blocked with 1% BSA in
PBS. Coverslips were incubated at 4°C overnight in pri-
mary antibodies. To evaluate the susceptibility to
CHIKV infection of HS 633T and HT-1080, a single
immunostaining was performed with a human specific
CHIKV antiserum (FDO, 1:4000 dilution). To determine
if the nuclear translocation of pSTAT1 in infected HS
633T cells, a double immunostaining was performed
with the following primary antibodies: monoclonal
mouse anti-CHIKV (1:1000 dilution, as described [32] to
detect the E1 envelope glycoprotein (a kind gift from
Biomérieux, Marcy l’Etoile, France) or CHIKV antiserum
FDO (1:4000 dilution) and polyclonal rabbit anti-human
phosphoSTAT1 (1:200 dilution) (Millipore-Chemicon,
07–307). After washings, coverslips were incubated at
room temperature for 2 h in secondary antibodies
diluted at 1:1000. Goat anti-human Alexa Fluor 488 IgG
(H + L), goat anti-mouse Alexa Fluor 488 IgG (H + L)
and donkey anti-rabbit Alexa Fluor 594 IgG (H + L)
(Invitrogen Molecular Probes) were used as secondary
antibodies. Nuclei were stained with DAPI (Sigma,
D9542) at a final concentration of 0.1 ng/mL. Coverslips
were mounted in Vectashield (Vector Labs; Clin-
iscience), and fluorescence was observed using a Nikon
Eclips 80i microscope. Images were obtained using the
Nikon Digital camera system (Nikon, DXM1200C) and
the imaging software NIS-Element BR version 3.1
(Nikon). Cells positive for pSTAT1 were counted in
three random fields at 40X to evaluate the inhibition of
pSTAT1 nuclear translocation in either HS 633T or
HT-1080 mock-infected and unstimulated; mock-
infected and IFN-α stimulated; CHIKV-infected and un-
stimulated; CHIKV-infected and IFN-α stimulated.
Quantitative real-time RT-PCR (CHIKV E1 gene)
Supernatants were sampled from HS 633T or HT-1080
cell cultures and lysis buffer (NucliSENSW easyMAGW,
280134) was added v/v in a final volume of 1 mL. Total
RNA was extracted from 200μL of supernatants in the
easyMAG machine (BIOMERIEUX), according to the
manufacturer protocol. A one step qRT-PCR was
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extracted RNA, 10μL of 2X SuperScriptW III PlatinumW
buffer (invitrogen), 10 μM of CHIKV E1 primers
(Forward primer: AAG CTY CGC GTC CTT TAC CAA
G, Reverse primer: CCA AAT TGT CCY GGT CTT
CCT), 5 μM of probe (6 Fam-CCA ATG TCY TCM
GCC TGG ACA CCT TT-Tamra), 40U/μL of RNAse
Inhibitor (RNAsin, N2511, Promega), 1U/μL of uracil-
DNA-glycosylase (UDG, 03539806001, RocheW), and
0.8μL of SuperScriptW III RT/PlatinumW Taq Enzyme
Mix (invitrogren). qRT-PCRs was carried out in the
LightCycler machine (version 1.5, RocheW) with the fol-
lowing steps: RT at 50°C for 20 min, PCR for pre-
denaturation at 95°C for 2 min, 45 cycles of denaturation
at 95°C for 5 sec and annealing at 60 °C for 1 min.
Quantitative real time RT-PCR for innate immune genes
Total RNA was extracted with TrizolW Reagent (Life
Technologies, Cat # 15596–026). qRT-PCR experiments
were done either using a one step qRT-PCR procedure
with TaqMan probes or a two step qRT-PCR assay in
presence of a DNA-binding dye. All experiments were
monitored on a LightCyclerW 480 Instrument (Roche
Diagnostics Ltd). The expression of RIG-I, ISG20, ISG54Table 1 List of primers for quantitative RT-PCR
Reference Gene Primer 5' modification
Primer and probes used for the o
NM_002201.4 ISG20 ISG20-636 F
ISG20-764R
ISG20-688P HEX
NM_002201.4 ISG54 ISG54-76 F
ISG54-219R
ISG54-124P FAM
NM_001548.3 ISG56 ISG56-131 F
ISG56-347R
ISG56-215P HEX






Primers used for the RT-q
NM_002176.2 IFN-β F GTTCGTGTTGTCAACA
R TCAATTGCCACAGGAG
NM_016562.3 TLR7 F CCACAACCAACTGACC
R CCACCAGACAAACCA
NM_002046.3 GAPDH F GCACCGTCAAGGCTG
R GCCTTCTCCATGGTGGand ISG56 (see Table 1) was assessed by a one-step
quantitative RT-PCR performed using the One Step Pri-
meScript™ RT-PCR kit from TAKARA (Cat #RR064A,
V.0701). Expression of IFN-β and TLR7 (see Table 1)
was assessed by RT followed by a quantitative PCR using
BRYT Green W (Promega, Cat #A6001/2). In both proce-
dures GAPDH was used as a housekeeping gene against
which the gene relative expression was determined
according to Pfaffl method [36]. All experiments were
done in triplicate and relative expression levels were
ploted with the software SigmaPlot version 12.0. Nega-
tive controls were included and PCR efficiency was
determined from the slope of a dilution curve.
Statistics
Percentages of infected HS 633T or HT-1080 cells, relative
gene expression levels and percentages of HS 633T or
HT-1080 cells with nuclear pSTAT1 were expressed as
mean ± standard error (SEM) of 3 independent experi-
ments, each using triplicate culture plates. Comparisons
between all treatments (CTL, 8, 24, 48 h PI) for HS 633T
or HT-1080 have been analyzed by a One-way ANOVA
test. Values of p < 0.05 were considered statistically signifi-
cant for a post-hoc Tukey-Kramer test in order toSequence (5' to 3') 3' modification
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gene expression between HS 633T and HT-1080 for each
treatment mentioned above has been analyzed by a Two-
way ANOVA test. Values of p < 0.05 were considered sta-
tistically significant to perform a Bonferroni post-hoc test.
Inhibition of nuclear pSTAT1 translocation in both cell
lines has been analyzed with a Student unpaired t test. All
statistical tests were done using GraphPad Prism version
5.01. Degrees of significance are indicated in the figure
caption as follow: * p < 0.05; ** p < 0.01; *** p < 0.001.
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